Published in Expert Opin Drug Discov on June 09, 2009
Proteomic screening of molecular targets of crocin. Daru (2014) 0.79
Drug target identification using network analysis: Taking active components in Sini decoction as an example. Sci Rep (2016) 0.77
A Novel Drug-Mouse Phenotypic Similarity Method Detects Molecular Determinants of Drug Effects. PLoS Comput Biol (2016) 0.75
Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology (2005) 3.83
Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci U S A (2008) 3.41
FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho. J Cell Physiol (2008) 3.10
GOAT links dietary lipids with the endocrine control of energy balance. Nat Med (2009) 2.42
Comprehensive label-free method for the relative quantification of proteins from biological samples. J Proteome Res (2005) 1.81
Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho. Science (2003) 1.77
New transmembrane AMPA receptor regulatory protein isoform, gamma-7, differentially regulates AMPA receptors. J Neurosci (2007) 1.62
Kinomics-structural biology and chemogenomics of kinase inhibitors and targets. Biochim Biophys Acta (2004) 1.43
Strategic use of immunoprecipitation and LC/MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis. Anal Chem (2007) 1.36
Characteristic physical properties and structural fragments of marketed oral drugs. J Med Chem (2004) 1.36
Estimating the statistical significance of peptide identifications from shotgun proteomics experiments. J Proteome Res (2007) 1.30
The effects of vertical sleeve gastrectomy in rodents are ghrelin independent. Gastroenterology (2012) 1.28
Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase. Biochem Biophys Res Commun (2002) 1.14
The impact of blood contamination on the proteome of cerebrospinal fluid. Proteomics (2005) 1.12
Proteomics: from hypothesis to quantitative assay on a single platform. Guidelines for developing MRM assays using ion trap mass spectrometers. Brief Funct Genomic Proteomic (2008) 1.04
The role of mass spectrometry in biomarker discovery and measurement. Curr Drug Metab (2006) 1.03
Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitor. J Cell Biochem (2007) 0.99
Label-free LC-MS method for the identification of biomarkers. Methods Mol Biol (2008) 0.93
A proteomic analysis of adult rat bone reveals the presence of cartilage/chondrocyte markers. J Cell Biochem (2007) 0.92
Quantitative analysis of amyloid-beta peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometry. Brief Funct Genomic Proteomic (2007) 0.92
Quantitative determination of peptides using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Biotechniques (2005) 0.89
Recombinant human thrombomodulin inhibits arterial neointimal hyperplasia after balloon injury. J Vasc Surg (2004) 0.88
Geometric accuracy of three-dimensional molecular overlays. J Chem Inf Model (2006) 0.86
Chemical fragments as foundations for understanding target space and activity prediction. J Med Chem (2008) 0.85
Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT. Biochem Pharmacol (2003) 0.85
An immuno-chemo-proteomics method for drug target deconvolution. J Proteome Res (2008) 0.84
A quantitative tool to distinguish isobaric leucine and isoleucine residues for mass spectrometry-based de novo monoclonal antibody sequencing. J Am Soc Mass Spectrom (2014) 0.82
Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasma. Anal Biochem (2013) 0.82
Development of a highly sensitive, high-throughput, mass spectrometry-based assay for rat procollagen type-I N-terminal propeptide (PINP) to measure bone formation activity. J Proteome Res (2007) 0.80
Quantification of heart fatty acid binding protein as a biomarker for drug-induced cardiac and musculoskeletal necroses. Proteomics Clin Appl (2007) 0.79
Proteomic analysis of demyelinated and remyelinating brain tissue following dietary cuprizone administration. J Mol Neurosci (2010) 0.79
From ghrelin to ghrelin's O-acyl transferase. Methods Enzymol (2012) 0.78
Structure-guided expansion of kinase fragment libraries driven by support vector machine models. Biochim Biophys Acta (2009) 0.77
Capture of drug targets from live cells using a multipurpose immuno-chemo-proteomics tool. J Proteome Res (2009) 0.77
Identifying pharmacodynamic protein markers of centrally active drugs in humans: a pilot study in a novel clinical model. J Proteome Res (2007) 0.75
Circulating Markers Reflect Both Anti- and Pro-Atherogenic Drug Effects in ApoE-Deficient Mice. Biomark Insights (2008) 0.75
Evaluating the performances of quantitative structure-retention relationship models with different sets of molecular descriptors and databases for high-performance liquid chromatography predictions. J Chromatogr A (2009) 0.75
Quantitative biological mass spectrometry. Editorial. Brief Funct Genomic Proteomic (2008) 0.75